Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
4.450
+0.030 (0.68%)
At close: Mar 17, 2026, 4:00 PM EDT
4.770
+0.320 (7.19%)
Pre-market: Mar 18, 2026, 5:57 AM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $68.86 million as of March 18, 2026. Its market cap has increased by 155.98% in one year.
Market Cap
68.86M
Enterprise Value
50.19M
1-Year Change
155.98%
Ranking
Category
Stock Price
$4.45
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $68.86M, a decrease of -98.99%. That is a compound annual growth rate of -33.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 68.90M | 40.90% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 74.63M |
| MediciNova | 72.36M |
| BeyondSpring | 72.19M |
| Adicet Bio | 69.00M |
| XBiotech | 68.60M |
| Actuate Therapeutics | 64.38M |
| Entera Bio | 64.20M |
| ImageneBio | 64.14M |